21 Sep 2016 07:00
For immediate release | 21 September 2016 |
Verseon Corporation
("Verseon" or the "Company")
Director/PDMR Shareholding
Verseon, a technology-based pharmaceutical company, has received notification that Eniko Fodor, the Chief Operating Officer and Chief Financial Officer of the Company, has purchased 6,000 common shares of par value $0.001 each in the Company ("Common Shares") at a purchase price of £1.61 per Common Share.
Following the purchase, Ms. Fodor will hold 31,008,486 Common Shares, representing approximately 20.5% of the Company's issued share capital.
For further information please contact:
Verseon Corporation | +1 (510) 225 9000 |
Arthur Shmurun / Amy Thai | |
Cenkos Securities (NOMAD and Broker) | +44 (0) 20 7397 8900 |
Mark Connelly / Steve Cox | |
Buchanan Communications Ltd (PR Advisers) | +44 (0) 20 7466 5000 |
Henry Harrison-Topham / Sophie Cowles |
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Eniko Fodor | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Director and Officer | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Verseon Corporation | ||||
b)
| LEI
| N/a | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Common Shares of par value $0.001
ISIN: USU9221J1098 | ||||
b)
| Nature of the transaction
| Purchase of Common Shares | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
6,000
£1.61
| ||||
e)
| Date of the transaction
| 19 September 2016 | ||||
f)
| Place of the transaction
| N/a | ||||